MICHELLE JONES: Open Payments
NPI 1972042968 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,754 in 16 payments from 14 companies in 2025. Trend: 2023 $2,585 · 2024 $2,098 · 2025 $1,754
Food & beverage: $1,754
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $282 |
| E.R. Squibb & Sons, L.L.C. | 2 | $236 |
| Madrigal Pharmaceuticals | 1 | $131 |
| Axsome Therapeutics, Inc. | 1 | $130 |
| Amgen Inc. | 1 | $130 |
| Vanda Pharmaceuticals Inc. | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $119 |
| Gilead Sciences, Inc. | 1 | $111 |
Products named: APOLLO ESG System, COBENFY, REZDIFFRA, Auvelity, EVENITY, FANAPT, AUSTEDO XR, REXULTI.
Industry payments across IL — which companies pay providers there.
